Sutro Biopharma (STRO) Cash from Operations Growth (3y) (2020 - 2025)
Sutro Biopharma (STRO) Cash from Operations Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 33.08% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -3.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.47% |
| Sep 30, 2025 | -37.15% |
| Jun 30, 2025 | -141.23% |
| Mar 31, 2025 | -24.41% |
| Dec 31, 2024 | -49.24% |
| Sep 30, 2024 | -38.27% |
| Jun 30, 2024 | 56.00% |
| Mar 31, 2024 | -28.62% |
| Dec 31, 2023 | 40.02% |
| Sep 30, 2023 | -23.72% |
| Jun 30, 2023 | -35.64% |
| Mar 31, 2023 | -48.21% |
| Dec 31, 2022 | -21.96% |
| Sep 30, 2022 | 82.57% |
| Jun 30, 2022 | 41.11% |
| Mar 31, 2022 | -20.51% |
| Dec 31, 2021 | -53.77% |
| Sep 30, 2021 | -35.96% |
| Jun 30, 2021 | 27.73% |
| Mar 31, 2021 | -26.56% |